Table 1

Patient data

Gleason grade/lymph nodeSample IDAgePreop PSA (ng/ml)Tumor-Node-Metastasis (97)Metastatic site
6/Negative6N 1559.4T2b,N0−
6N 2507.5T2b,N0−
6N 35710.3T2b,N0−
6N 46716.7T2b,N0−
6N 5688.1T2a,N0−
6/Positive6P 17117.1T2b,N1+
6P 2615.2T2b,N0+
6P 37141.0T2b,N0+
6P 4657.0T2a,N0+
6P 55114.3T2b,N0+
6P 66623.5T2b,N0+
9/Negative9N 16721.6T3a,N0−
9N 26529.4T3b,N0−
9N 36524.9T3b,N0−
9N 45450.0T3b,N0−
9N 55925.8T3b,N0−
9N 6716.1T3b,N0−
9/Positive9P 1664.5T3a,N0+
9P 2656.69T3b,N0+
9P 3767.6T3b,N1+
9P 471467.0T3b,N0+
9P 5695.6T3b,N0+
9P 6662.9T3b,N1−
MetastaticMet 1620.15Liver
Met 27297.3Peritoneum
Met 3490.15Lymph node
Met 46018.4Lymph node
Met 5688.9Lung